The Use of Cannabis (Marijuana) and Cannabidiol (CBD) Among Cancer Patients: A Pilot Study
2 other identifiers
observational
100
1 country
1
Brief Summary
To collect information about how patients in the pain management clinic use cannabis/CBD, including how often it is used, why it is used (for example, to manage pain or other symptoms), and where patients get their information on cannabis/CBD for pain management
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 30, 2023
CompletedFirst Submitted
Initial submission to the registry
April 19, 2023
CompletedFirst Posted
Study publicly available on registry
May 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 31, 2027
April 16, 2026
April 1, 2026
4.3 years
April 19, 2023
April 13, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Cannabis (Marijuana) and CBD (Cannabidiol for Cancer Pain Survey
Score scale ranges from 1-5, Extremely interested(1),Not Interested (5)
through study completion; an average of 1 year.
Study Arms (1)
Cannabis (Marijuana) and Cannabidiol (CBD)
This is a survey to determine the number of cancer pain patients who use and/or used Marijuana and/or CBD for pain or other symptom burdens.
Interventions
The level of interest in learning more about cannabis for cancer pain, we can better facilitate a patient-centered approach to comprehensive treatment plans through patient education.
The level of interest in learning more about cannabis for cancer pain, we can better facilitate a patient-centered approach to comprehensive treatment plans through patient education
Eligibility Criteria
M D Anderson Cancer Center
You may qualify if:
- Age 18 years or older
- Cancer patients who present to the MD Anderson Pain Medicine Clinic as a new patient or consult
- Willing to give informed consent
- Willing to complete the survey
You may not qualify if:
- Refusal of informed consent
- Refusal to complete the survey
- Patients who previously completed the survey
- Patients who opt-out or change their mind after agreeing to participate
- Already an established patient at MDACC Pain Medicine Clinic
- Patients scheduled to see Dr Abdi (PI).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Salahadin Abdi, MD,PHD
M.D. Anderson Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 19, 2023
First Posted
May 1, 2023
Study Start
January 30, 2023
Primary Completion (Estimated)
May 31, 2027
Study Completion (Estimated)
May 31, 2027
Last Updated
April 16, 2026
Record last verified: 2026-04